Financial Results - Standalone (₹ in million)

Income Statement:

  • Revenue from operations: ₹589.84 (Q1 FY2027) vs ₹437.04 (Q1 FY2026)
  • Other income: ₹70.28 (Q1 FY2027) vs ₹23.61 (Q1 FY2026)
  • Total income: ₹660.12 (Q1 FY2027) vs ₹460.65 (Q1 FY2026)

Expenses:

  • Employee benefits expense: ₹132.00
  • Finance costs: ₹11.12
  • Depreciation and amortization: ₹48.81
  • Other expenses: ₹291.20
  • Total expenses: ₹483.13

Profitability:

  • Profit before exceptional items and tax: ₹176.99 vs ₹108.53 (YoY)
  • Exceptional items: Nil (₹0.52 million in FY2026)
  • Profit before tax: ₹176.99 vs ₹108.53 (YoY)
  • Total tax expense: ₹45.47 (Current tax: ₹31.78, Deferred tax: ₹13.69)
  • Net profit: ₹131.52 vs ₹80.20 (YoY)
  • Other comprehensive income: ₹5.87
  • Total comprehensive income: ₹137.39

Share Capital and EPS:

  • Paid-up equity share capital: ₹373.51 million (face value ₹5 each)
  • Basic EPS: ₹1.76 vs ₹1.14 (YoY)
  • Diluted EPS: ₹1.76 vs ₹1.13 (YoY)

Financial Results - Consolidated (₹ in million)

Income Statement:

  • Revenue from operations: ₹2,365.19 (Q1 FY2027) vs ₹1,905.58 (Q1 FY2026)
  • Other income: ₹104.97 (Q1 FY2027) vs ₹72.86 (Q1 FY2026)
  • Total income: ₹2,470.16 (Q1 FY2027) vs ₹1,978.44 (Q1 FY2026)

Expenses:

  • Employee benefits expense: ₹1,032.60
  • Finance costs: ₹17.59
  • Depreciation and amortization: ₹218.47
  • Other expenses: ₹852.43
  • Total expenses: ₹2,121.09

Profitability:

  • Profit before exceptional items and tax: ₹349.07 vs ₹305.12 (YoY)
  • Exceptional items: Nil (₹141.95 million in FY2026)
  • Profit before tax: ₹349.07 vs ₹305.12 (YoY)
  • Total tax expense: ₹73.10 (Current tax: ₹32.92, Deferred tax: ₹40.18)
  • Net profit: ₹275.97 vs ₹226.31 (YoY)
  • Other comprehensive income: ₹10.96
  • Total comprehensive income: ₹286.93

Share Capital and EPS:

  • Paid-up equity share capital: ₹373.51 million
  • Basic EPS: ₹3.71 vs ₹3.18 (YoY)
  • Diluted EPS: ₹3.70 vs ₹3.16 (YoY)

Subsidiary Updates and Corporate Actions

Enforcement Directorate Search:

  • On April 4, 2025, ED conducted search and seizure operation at offices of wholly-owned subsidiary Medi Assist Insurance TPA Private Limited (MAITPA) in Ranchi, Jharkhand
  • MAITPA administers Ayushman Bharat-linked health scheme in Jharkhand
  • No communication received from ED regarding outcome as of August 8, 2026
  • Management assessment: No adverse impact on company, no adjustment required in financial results

Paramount TPA Acquisition:

  • Completed acquisition of 100% equity stake in Paramount Health Services and Insurance TPA Private Limited on July 1, 2025
  • Purchase consideration: ₹4,124.40 million after closing adjustments
  • Enterprise value: ₹3,118.00 million as per Share Purchase Agreement dated August 26, 2024
  • IRDAI approval received on May 13, 2025

Cyber Security Incident:

  • Paramount TPA experienced cyber-security incident during FY2026 impacting certain systems
  • Incident contained at Paramount TPA level, did not affect company or other subsidiaries
  • Costs incurred: ₹37.68 million (recognized as exceptional item in FY2026)
  • Insurance claim lodged under cyber-insurance policy
  • No additional adjustments considered necessary for Q1 FY2027

Fund Raising:

  • Preferential allotment of 37,01,000 equity shares at ₹535 per share (including premium of ₹530)
  • Aggregate consideration: ₹1,980.03 million
  • Allottees: Massachusetts Institute of Technology (28,90,830 shares, ₹1,546.59 million) and 238 Plan Associates LLC (8,10,170 shares, ₹433.44 million)
  • Unspent amount as of June 30, 2026: ₹448.80 million

Corporate Restructuring:

  • Scheme approved for merger of Paramount TPA with MAITPA (withdrawn on February 6, 2026)
  • Business Transfer Agreement executed transferring TPA business of Paramount TPA to MAITPA effective February 1, 2026
  • Scheme of Merger by Absorption of Paramount TPA with company approved, subject to regulatory approvals
  • IRDAI sought clarifications post-quarter end, joint response submitted

Mayfair We Care Acquisition:

  • Acquired additional 31.75% equity stake in Mayfair We Care Limited effective July 1, 2026
  • Advance payment: ₹47.17 million on June 30, 2026
  • Additional payment: ₹28.51 million on July 1, 2026
  • Derivative liability remeasurement gain: ₹31.18 million recognized as other income

Other Subsidiary Matters:

  • Scheme of Amalgamation of International Healthcare Management Services Private Limited with Mayfair Consultancy Services India Private Limited (appointed date April 1, 2025)
  • Filed with Regional Director, forwarded to NCLT Bengaluru on May 19, 2026
  • NCLT sought additional documents during quarter, matter pending

Emphasis of Matter

Auditors drew attention to Note 7 (standalone) and Note 8 (consolidated) regarding ED search operation at subsidiary office and management's assessment of no financial impact.

#Tags: #MediAssist #Q1Results #SEBIDisclosure #FinancialResults #HealthcareServices